Intra-patient Randomized Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT Follow up
Intra-patient Randomized Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT Follow up
The objective of the study is to evaluate the process of early re-endothelialization of the Coroflex® ISAR Drug-eluting stent compared with the Ultimaster® Drug-eluting stent
The objective of the study is to evaluate the process of early re-endothelialization of the Coroflex® ISAR Drug-eluting stent compared with the Ultimaster® Drug-eluting stent
Inclusion Criteria:
Aged ≥ 18 years
Signature of informed consent
Patients with angina and a clinical indication for coronary revascularisation with a drug-eluting stent
Presence of at least 2 lesions to be revascularised with similar angiographic characteristics
Exclusion Criteria:
Lesions due to restenosis
Lesions in saphenous vein grafts
STE-ACS ( ST elevation- Acute Coronary Syndrome)
Cardiogenic shock
Dual antiplatelet therapy contraindication for> 3 months
Follow-up catheterisation contraindicated
Ineligible for evaluation via optical coherence tomography
Bifurcation lesion requiring a strategy with two stents
Angiographic characteristics that promote stent malposition
Inability to do reliable follow-up, in the investigator's opinion